Navigation Links
Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
Date:10/21/2009

nths, a promising early result. Patient follow-up in the trial is continuing.

"The data released today continues to reinforce the positive results seen across the five cancer trials to date assessing the potential of bavituximab in different treatment combinations across multiple tumor types," said Steven W. King, president and CEO of Peregrine. "We believe this data in aggregate shows the broad potential of this novel therapeutic compound for the treatment of solid tumors. We look forward to reporting further results from our ongoing bavituximab studies and to providing more details on future clinical development plans as they are finalized over the coming months."

Secondary objectives of the study include measuring time to tumor progression, duration of response, overall patient survival and safety parameters. Patients in the study are evaluated regularly for tumor response according to RECIST criteria. Patients may continue to receive bavituximab as monotherapy after completion of chemotherapy as long as the cancer does not progress and side effects are acceptable.

The World Health Organization reports that breast cancer is the most commonly diagnosed cancer in women and is second only to lung cancer as a leading cause of female cancer deaths. The National Cancer Institute estimates that approximately 192,370 U.S. women will be diagnosed with breast cancer in 2009 and 40,170 women will die of the disease in the U.S. alone.

Bavituximab is a monoclonal antibody that targets the cellular membrane component phosphatidylserine (PS) that is usually located inside cells, but which becomes exposed on the outside of the cells that line the blood vessels of tumors, creating a specific target for anti-cancer treatments. Bavituximab acts by binding to externalized PS on tumor blood vessels and inducing immune cell-mediated destruction of these blood vessels. It also restores the immune system's ability to recognize and resp
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
2. Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
3. Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara(R) for Treatment of Brain Cancer
4. Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
5. Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients
6. Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies
7. Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrines Fully Human Anti-PS Antibody in Prostate Cancer Model
8. Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrines PS-Targeting Antibodies
9. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
10. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
11. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)...  Tokyo-based Atonarp Inc. announced today $8 million ... Walden Riverwood Ventures with participation from other co-investors.  ... Spectrometer technology platform, which will enable a broad ... oil & gas and healthcare industries for its ... partner with Atonarp in pursuing the commercialization of ...
(Date:8/19/2014)... 2014  AVIA – a provider-led accelerator that puts ... problems in healthcare ­– announces Sutter Health, a not-for-profit ... as the most recent addition to the AVIA Innovator ... AVIA,s inaugural cohort focused helping patients navigate the healthcare ... a patient,s providers so they work as a larger ...
(Date:8/19/2014)... , Aug. 19, 2014 According to ... component needed to make Big Data in healthcare a ... sales.  As part of the American Recovery and Reinvestment ... medical record (EMR) projects and penalties will start applying ... Kalorama Information, in its complete study of the EMR ...
Breaking Medicine Technology:Atonarp Inc. Raises $8M Series A Round Led by Walden Riverwood Ventures 2AVIA and Sutter Health Join Forces to Address Healthcare's Most Pressing Challenges 2Kalorama: EMR Paves the Way for Big Data 2Kalorama: EMR Paves the Way for Big Data 3
(Date:8/19/2014)... Top10BestSEOHosting.com has recently announced that ... recommended suppliers for the webmasters who want to ... According to the senior spokesman for Top10BestSEOHosting.com, these ... hosting products on the market and specializes in ... of online deals when service plans are purchased ...
(Date:8/19/2014)... has recently compared many popular hosting suppliers and announced ... recommended companies for webmasters who want to buy high ... an affordable price. , Both GoDaddy and iPage ... the lowest upfront costs (including some Joomla hosting products ... of options. , GoDaddy is a famous supplier ...
(Date:8/19/2014)... News) -- Lupus and other rheumatic diseases can ... which can delay a correct diagnosis for months, ... diseases can also cause these types of symptoms, ... in Maywood, Ill. Rheumatic disorders include autoimmune ... tissues, such as lupus, systemic vasculitis and ankylosing ...
(Date:8/19/2014)... ME (PRWEB) August 19, 2014 Drews Dental ... J. Drews, D.D.S., to vice president of the Maine Dental ... MDA for three years, Dr. Drews has now been sworn ... forward to serving his term as vice president and being ... as well as the First District Caucus in 2015. He ...
(Date:8/19/2014)... August 19, 2014 Following the completion of ... Hyatt Tampa Bay is proud to debut the highly ... project included a full revamp of all public spaces to ... rooms and suites, an all-new dining experience at 1823 Kitchen ... lobby. , With the introduction of 1823 Kitchen and Bar, ...
Breaking Medicine News(10 mins):Health News:Fatcow Awarded As One of the Best Web Hosting Suppliers at Top10bestseohosting.com 2Health News:Top10BestSEOHosting.com: Cheap Joomla Hosting Reviews Unveiled 2Health News:Certain Symptoms Can Delay Lupus Diagnosis, Researchers Report 2Health News:Dr. Drews Elected VP of Maine Dental Association 2Health News:Grand Hyatt Tampa Bay Hotel Unveils the Finishing Touches of Its $20 Million Makeover 2
... Hosts First Annual Exclusive Wine ... Gala, WASHINGTON, Dec. 14 Starlight Starbright,Children,s ... Annual Exclusive Wine Dinner and Eighth Annual Taste ... events were hosted at the,award-winning Michel Richard Citronelle ...
... Provides Reliable, Quick Patient-Information Retrieval From ... JOLIET, Ill., Dec. 14 AT&T Inc. ... Oncology-Hematology Associates, Ltd. (JOHA) has,awarded AT&T a ... in addition to other network solutions. Continuing ...
... 14 Barr Pharmaceuticals,Inc. (NYSE: BRL ) ... has filed suits against Watson Pharmaceuticals (NYSE:,WPI) and ... NVS ) for,infringement of the patent protecting Duramed,s ... litigation in the,U.S. District Court for the District ...
... Classification for Innovative New Treatments, AMSTERDAM, December ... product ATIR has received approval for regulatory,classification as ... Task,Force (ITF), a division of the European Medicines ... eligible for EMEA procedures. As a,next step Kiadis ...
... crowded roadways face more than 50% risk of breathing trouble, ... with asthma who are exposed to traffic pollution are at ... a study that looked at children in the Mexican border ... States. , "Major cities along the northern and southern ...
... LTC Financial Partners Offers Newsletter & Online Help for Living Longer, ... ... their,life spans, many eyeing 100-plus, the odds of needing long term care,increase. One ... says Cameron Truesdell, CEO of LTC Financial Partners,(LTCFP), "is the insurance plus health ...
Cached Medicine News:Health News:Premier Children's Charity Sets Fundraising Record With Back-to-Back Events 2Health News:Premier Children's Charity Sets Fundraising Record With Back-to-Back Events 3Health News:Premier Children's Charity Sets Fundraising Record With Back-to-Back Events 4Health News:Local Joliet Physician Group Selects AT&T for Managed Online Data Solutions 2Health News:Local Joliet Physician Group Selects AT&T for Managed Online Data Solutions 3Health News:Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement 2Health News:Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement 3Health News:Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement 4Health News:ATIR Classified as "Cell Based" Medicinal Product by the EMEA 2Health News: Traffic Pollution Hurts Asthmatic Kids' Lungs 2Health News:As More Americans Live to 100, Long Term Care Insurance Leader Gives Health Assist 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: